Daniel Backenroth
Johnson & Johnson (United States)
ORCID: 0000-0002-9581-8870Also affiliated with Johnson & Johnson (Israel)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Daniel Backenroth, Éadaoin Harney, Stefan Flohr, Nadia C. Neff, Gina Buckley +22 more
Papers
Driven by 4 papers — median percentile 35. Top paper: “Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial”.
An Vandebosch, Jerald Sadoff, Mathieu Le Gars, Carla Truyers, D. Lowson +95 more
Daniel Backenroth, Éadaoin Harney, Stefan Flohr, Nadia C. Neff, Gina Buckley +22 more
Daniel Backenroth, Einat Granot‐Hershkovitz, Adam Green, Kyle Gettler, Judy H. Cho +4 more
Daniel Backenroth, Éadaoin Harney, Stefan Flohr, Nadia C. Neff, Gina Buckley +27 more